在患有严重败血症的儿科患者中,基于机器学习的时间到事件生存分析
Qianru Huang1, Li Zheng2, Ruyi Cai3
1The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China.
Frontiers in pediatrics
|November 10, 2025
概括
机器学习模型准确地预测了儿科败血症生存时间,识别了早期干预的关键生物标志物,如和RDW. 这有助于改善重症儿童的预后.
科学领域:
- 儿科重症监护医药 儿科重症监护医药
- 发现生物标志物的发现.
- 机器学习在医疗保健中的应用
背景情况:
- 儿科败血症是全球重症儿童的主要死亡原因.
- 目前用于败血症的预后方法的准确性有限.
- 需要改进败血症预测模型.
研究的目的:
- 开发和验证用于预测儿科败血症生存时间的机器学习模型.
- 确定与败血症死亡率相关的关键临床因素和生物标志物.
- 提供一个工具,用于动态风险评估在儿科败血症.
主要方法:
- 对223名儿科败血症患者进行了回顾性队列研究.
- 评估了五种生存分析机器学习算法 (CoxPH,HingeLossSVM,GradientBoosting,RandomSurvivalForest,ExtraSurvivalTrees) 的使用情况.
- 使用时间依赖的AUC,c指数,Brier分数和校准曲线进行性能评估;通过SHAP分析进行可解释性.
主要成果:
- 随机生存森林显示了最高的预测性能 (td-AUC 0.97).
- 确定的主要死亡预测因素包括总,RDW,和pH.
- 这些生物标志物的确立临床值表明死亡风险增加.
结论:
- 机器学习,特别是RandomSurvivalForest,为儿科败血症提供了卓越的时间到事件预测.
- 这种方法可以实现动态风险评估和及时的临床干预.
- 为实际的临床应用而开发了一个基于网络的计算器.
相关概念视频
Introduction To Survival Analysis
727
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
727
Comparing the Survival Analysis of Two or More Groups
542
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
542
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Kaplan-Meier Approach
547
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
547
Actuarial Approach
281
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
281


